DORINDA BERRONG: Open Payments
NPI 1528171139 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,015 in 235 payments from 18 companies in 2025. Trend: 2023 $3,801 · 2024 $3,884 · 2025 $4,015
Food & beverage: $4,015
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 28 | $730 |
| Otsuka America Pharmaceutical, Inc. | 27 | $515 |
| ABBVIE INC. | 25 | $419 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $335 |
| Teva Pharmaceuticals USA, Inc. | 20 | $306 |
| E.R. Squibb & Sons, L.L.C. | 20 | $277 |
| Janssen Pharmaceuticals, Inc | 14 | $274 |
| Alkermes, Inc. | 14 | $203 |
| Tris Pharma Inc | 13 | $189 |
| Axsome Therapeutics, Inc. | 13 | $180 |
Products named: REXULTI, VRAYLAR, HETLIOZ, CAPLYTA, FANAPT, COBENFY, ARISTADA, SPRAVATO.
Industry payments across NC — which companies pay providers there.
